METRONIDazole Injection — Class II drug recall D-0480-2017
Terminated recall by Hospira Inc., A Pfizer Company, reported 2017-03-01, distributed nationwide. Lack of Sterility Assurance: customer report of leaking bag
| Recall number | D-0480-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., A Pfizer Company, Lake Forest, IL, United States |
| Recall initiated | 2017-02-10 |
| Classified | 2017-02-17 |
| Reported by FDA | 2017-03-01 |
| Terminated | 2019-04-03 |
| Distributed | Nationwide (US) |
| Quantity | 578,784 bags |
| Reason classes | sterility, packaging |
| NDC | 00409-7811-24 |
| Lot numbers | 54-054-JT |
Product
METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24
Reason for recall
Lack of Sterility Assurance: customer report of leaking bag
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0480-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.